Related Experiment Video
Updated: May 29, 2026
09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Host Response Diagnostics in Pneumonia
Chiagozie Pickens1, Charles S Dela Cruz2
1Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Clinics in Chest Medicine
|May 27, 2026
Summary
Critically ill, immunocompromised patients with respiratory failure need accurate diagnosis. This chapter reviews sampling and diagnostic methods, including novel molecular tests, to improve identification of infection causes.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonary Medicine
Background:
- Immunocompromised patients face diverse respiratory infections, from common to rare.
- Accurate diagnosis is crucial for effective treatment, prognosis, and public health.
- Current diagnostic approaches have limitations, especially in complex cases.
Purpose of the Study:
- To review sampling and diagnostic techniques for respiratory infections in immunocompromised patients.
- To discuss the advantages and limitations of various diagnostic methods.
- To explore the role of novel molecular diagnostics in this patient population.
Main Methods:
- Review of current literature on respiratory infection diagnosis in immunocompromised individuals.
- Discussion of traditional and advanced microbiologic diagnostic techniques.
- Analysis of sampling strategies and their impact on diagnostic yield.
Main Results:
- No specific results mentioned as this is a review chapter.
- Highlights the broad spectrum of potential pathogens.
- Emphasizes the need for tailored diagnostic approaches.
Conclusions:
- Understanding diagnostic limitations is key for immunocompromised patients.
- Novel molecular diagnostics show promise but require further clinical impact assessment.
- Optimizing sampling and diagnostic strategies is essential for managing respiratory failure in this vulnerable group.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: